Cargando…

Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination

A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimm...

Descripción completa

Detalles Bibliográficos
Autores principales: Brubaker, Jon Elliott D, Casaccio, Christopher L, Brazeau, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236645/
https://www.ncbi.nlm.nih.gov/pubmed/35774705
http://dx.doi.org/10.7759/cureus.25339
_version_ 1784736580387209216
author Brubaker, Jon Elliott D
Casaccio, Christopher L
Brazeau, Michael J
author_facet Brubaker, Jon Elliott D
Casaccio, Christopher L
Brazeau, Michael J
author_sort Brubaker, Jon Elliott D
collection PubMed
description A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients.
format Online
Article
Text
id pubmed-9236645
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92366452022-06-29 Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination Brubaker, Jon Elliott D Casaccio, Christopher L Brazeau, Michael J Cureus Internal Medicine A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients. Cureus 2022-05-25 /pmc/articles/PMC9236645/ /pubmed/35774705 http://dx.doi.org/10.7759/cureus.25339 Text en Copyright © 2022, Brubaker et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Brubaker, Jon Elliott D
Casaccio, Christopher L
Brazeau, Michael J
Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title_full Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title_fullStr Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title_full_unstemmed Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title_short Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
title_sort recurrence of autoimmune hepatitis after covid-19 vaccination
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236645/
https://www.ncbi.nlm.nih.gov/pubmed/35774705
http://dx.doi.org/10.7759/cureus.25339
work_keys_str_mv AT brubakerjonelliottd recurrenceofautoimmunehepatitisaftercovid19vaccination
AT casacciochristopherl recurrenceofautoimmunehepatitisaftercovid19vaccination
AT brazeaumichaelj recurrenceofautoimmunehepatitisaftercovid19vaccination